ATE424822T1 - Tetrahydro-beta-karbolin-sulfonamid-derivate als 5-ht6-liganden - Google Patents
Tetrahydro-beta-karbolin-sulfonamid-derivate als 5-ht6-ligandenInfo
- Publication number
- ATE424822T1 ATE424822T1 AT06818244T AT06818244T ATE424822T1 AT E424822 T1 ATE424822 T1 AT E424822T1 AT 06818244 T AT06818244 T AT 06818244T AT 06818244 T AT06818244 T AT 06818244T AT E424822 T1 ATE424822 T1 AT E424822T1
- Authority
- AT
- Austria
- Prior art keywords
- tetrahydro
- sulfonamide derivatives
- carboline
- ligands
- beta
- Prior art date
Links
- AOJBGFBXKDJAPY-UHFFFAOYSA-N 2,3,4,9-tetrahydro-1h-pyrido[3,4-b]indole-1-sulfonamide Chemical class N1C2=CC=CC=C2C2=C1C(S(=O)(=O)N)NCC2 AOJBGFBXKDJAPY-UHFFFAOYSA-N 0.000 title 1
- 239000003446 ligand Substances 0.000 title 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 108091005435 5-HT6 receptors Proteins 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 229940124530 sulfonamide Drugs 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05380174A EP1747779A1 (de) | 2005-07-28 | 2005-07-28 | Tetrahydro-b-carbolinsulfonamid-Derivate als 5-HT6 Liganden |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE424822T1 true ATE424822T1 (de) | 2009-03-15 |
Family
ID=35559403
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06818244T ATE424822T1 (de) | 2005-07-28 | 2006-07-26 | Tetrahydro-beta-karbolin-sulfonamid-derivate als 5-ht6-liganden |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8263609B2 (de) |
| EP (2) | EP1747779A1 (de) |
| JP (1) | JP2009502840A (de) |
| CN (1) | CN101272785A (de) |
| AT (1) | ATE424822T1 (de) |
| CA (1) | CA2616729A1 (de) |
| DE (1) | DE602006005685D1 (de) |
| ES (1) | ES2321879T3 (de) |
| PT (1) | PT1919475E (de) |
| WO (1) | WO2007028460A1 (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10252667A1 (de) | 2002-11-11 | 2004-05-27 | Grünenthal GmbH | Spirocyclische Cyclohexan-Derivate |
| DE102005016460A1 (de) * | 2005-04-11 | 2006-10-19 | Grünenthal GmbH | Spriocyclische Cyclohexanderivate zur Behandlung von Substanzabhängigkeit |
| DE102007009235A1 (de) * | 2007-02-22 | 2008-09-18 | Grünenthal GmbH | Spirocyclische Cyclohexan-Derivate |
| EP2020230B1 (de) * | 2007-08-01 | 2011-01-19 | Laboratorios del Dr. Esteve S.A. | Kombination von mindestens zwei 5-HT6-Liganden |
| AU2008302751A1 (en) * | 2007-09-20 | 2009-03-26 | D2E, Llc | Fluoro-containing derivatives of hydrogenated pyrido[4,3-b]indoles with neuroprotective and cognition enhancing properties, process for preparing, and use |
| EP2053052A1 (de) | 2007-10-23 | 2009-04-29 | Laboratorios del Dr. Esteve S.A. | Verfahren zur Herstellung von 6-substituiertem Imidazo[2,1-b]thiazol-5-sulfonylhalogenid |
| TWI443098B (zh) * | 2008-03-24 | 2014-07-01 | Medivation Technologies Inc | 吡啶并〔３，４－ｂ〕吲哚及使用方法 |
| HRP20140650T1 (hr) * | 2008-03-27 | 2014-09-26 | Grünenthal GmbH | Hidroksimetilcikloheksilamini |
| CL2009000731A1 (es) * | 2008-03-27 | 2009-05-15 | Gruenenthal Gmbh | Compuestos derivados de ciclohexano espirociclicos sustituidos, composicion farmaceutica que contiene a dicho compuesto y su uso como moduladores del receptor de opioides µ y el receptor orl-1 para tratar el dolor, ansiedad, depresion, epilepsia, alzheimer, abuso de alcohol, hipertension, anorexia, obesidad y diarrea. |
| KR20120075500A (ko) | 2008-03-27 | 2012-07-06 | 그뤼넨탈 게엠베하 | 치환된 4-아미노사이클로헥산 유도체 |
| EP2260022B1 (de) * | 2008-03-27 | 2017-01-04 | Grünenthal GmbH | Substituierte cyclohexyldiamine |
| JP5542119B2 (ja) * | 2008-03-27 | 2014-07-09 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | スピロ（５．５）ウンデカン誘導体 |
| EP2116546A1 (de) | 2008-05-09 | 2009-11-11 | Laboratorios Del. Dr. Esteve, S.A. | Substituierte N-Phenyl-2,3-dihydroimidazo[2,1-b]thiazol-5-sulfonamid-Derivative als 5-HT6-Liganden |
| EP2116547A1 (de) | 2008-05-09 | 2009-11-11 | Laboratorios Del. Dr. Esteve, S.A. | Substituierte n-Imidazo[2,1-b]thiazol-5-sulfonamid-Derivative als 5-TH6-Liganden |
| US9625475B2 (en) | 2008-09-29 | 2017-04-18 | Abbvie Inc. | Indole and indoline derivatives and methods of use thereof |
| TW201018694A (en) | 2008-09-29 | 2010-05-16 | Abbott Lab | Indole and indoline derivatives and methods of use thereof |
| US9353113B2 (en) | 2011-03-18 | 2016-05-31 | Ono Pharmaceutical Co., Ltd. | Tetrahydrocarboline derivative |
| CN104557664B (zh) * | 2013-10-19 | 2020-01-21 | 广东东阳光药业有限公司 | 芳杂环类衍生物及其在药物上的应用 |
| CN107686511A (zh) * | 2016-08-05 | 2018-02-13 | 首都医科大学 | 甲基四氢‑β‑咔啉‑3‑甲酰YIGS肽,其合成,抗血栓作用和应用 |
| CN107686510A (zh) * | 2016-08-05 | 2018-02-13 | 首都医科大学 | 甲基四氢‑β‑咔啉‑3‑甲酰RGD肽,其合成,抗血栓作用和应用 |
| JP2023539390A (ja) * | 2020-09-02 | 2023-09-13 | エンベリック バイオサイエンシズ カナダ インコーポレイテッド | ニトロ化サイロシビン誘導体ならびに５－ｈｔ２ａ受容体を調節するためおよび精神障害を処置するためのその使用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1234567A (en) * | 1915-09-14 | 1917-07-24 | Edward J Quigley | Soft collar. |
| AU6298196A (en) | 1995-06-23 | 1997-01-22 | Novo Nordisk A/S | Tetrahydro-betacarboline derivatives and their preparation and use |
| BR9814340B1 (pt) | 1997-12-24 | 2010-07-13 | compostos derivados de indol, processo para a preparação dos mesmo e composição farmacêutica. | |
| JP2004509894A (ja) * | 2000-09-20 | 2004-04-02 | ファルマシア・アンド・アップジョン・カンパニー | 置換アゼピノ［４，５−ｂ］インドリン誘導体 |
| US7022856B2 (en) | 2001-02-12 | 2006-04-04 | Lilly Icos Llc. | Carboline derivatives |
| MXPA03007142A (es) | 2001-02-12 | 2004-05-24 | Lilly Icos Llc | Derivados de carbolina. |
| MXPA03009750A (es) | 2001-04-25 | 2004-06-30 | Lilly Icos Llc | Compuestos quimicos. |
| JP2004534017A (ja) * | 2001-04-27 | 2004-11-11 | バーテックス ファーマシューティカルズ インコーポレイテッド | Ｂａｃｅのインヒビター |
| US6992192B2 (en) | 2001-06-05 | 2006-01-31 | Lilly Icos Llc. | Carboline derivatives as PDE5 inhibitors |
| EP1434578A1 (de) * | 2001-10-09 | 2004-07-07 | PHARMACIA & UPJOHN COMPANY | Arylsulphonyl substituirte tetrahydro- und hexahydro-carbazole als 5-ht-6 receptor liganden |
| TW200524864A (en) * | 2003-11-10 | 2005-08-01 | Wyeth Corp | Sulfonyltetrahydro-3H-benzo(E)indole-8-amine compounds as 5-hydroxytryptamine-6 ligands |
| WO2006040180A1 (en) * | 2004-10-14 | 2006-04-20 | Abbott Gmbh & Co. Kg | Aminomethyl substituted bicyclic aromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
-
2005
- 2005-07-28 EP EP05380174A patent/EP1747779A1/de not_active Withdrawn
-
2006
- 2006-07-26 CN CNA2006800357135A patent/CN101272785A/zh active Pending
- 2006-07-26 AT AT06818244T patent/ATE424822T1/de not_active IP Right Cessation
- 2006-07-26 PT PT06818244T patent/PT1919475E/pt unknown
- 2006-07-26 WO PCT/EP2006/007358 patent/WO2007028460A1/en not_active Ceased
- 2006-07-26 JP JP2008523229A patent/JP2009502840A/ja active Pending
- 2006-07-26 US US11/997,136 patent/US8263609B2/en not_active Expired - Fee Related
- 2006-07-26 ES ES06818244T patent/ES2321879T3/es not_active Expired - Lifetime
- 2006-07-26 DE DE602006005685T patent/DE602006005685D1/de not_active Expired - Lifetime
- 2006-07-26 CA CA002616729A patent/CA2616729A1/en not_active Abandoned
- 2006-07-26 EP EP06818244A patent/EP1919475B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE602006005685D1 (de) | 2009-04-23 |
| PT1919475E (pt) | 2009-05-05 |
| JP2009502840A (ja) | 2009-01-29 |
| HK1120725A1 (en) | 2009-04-09 |
| EP1747779A1 (de) | 2007-01-31 |
| US8263609B2 (en) | 2012-09-11 |
| US20080280942A1 (en) | 2008-11-13 |
| CN101272785A (zh) | 2008-09-24 |
| ES2321879T3 (es) | 2009-06-12 |
| EP1919475B1 (de) | 2009-03-11 |
| EP1919475A1 (de) | 2008-05-14 |
| WO2007028460A1 (en) | 2007-03-15 |
| CA2616729A1 (en) | 2007-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602006005685D1 (de) | Tetrahydro-beta-karbolin-sulfonamid-derivate als 5-ht6-liganden | |
| PA8580301A1 (es) | Nuevos derivados de benzoimidazol utiles como agentes antiproliferativos | |
| DE60330187D1 (de) | Fluoralkoxy-substituierte 1, 3-dihydro-isoindolyl-verbindungen und ihre pharmazeutischen verwendungen | |
| TW200726765A (en) | Triazolopyridine cannabinoid receptor 1 antagonists | |
| EA200600892A1 (ru) | Новые хинолиновые производные | |
| IS8502A (is) | Azatvíhringja heteróhringir sem kannabínóíð-viðtakastillar | |
| NO20080670L (no) | Substituerte piperaziner som metabotrofiske glutamatreseptorantagonister | |
| EA200500018A1 (ru) | Бензконденсированные гетероариламидные производные тиенопиридинов, применяемые в качестве терапевтических агентов, фармацевтические композиции, включающие их, и способы их применения | |
| MA26904A1 (fr) | Aminoalkyl 1-lactames substituees et leur utilisation en tant qu'antagonistes du recepteur muscarinique. | |
| TW200509907A (en) | Indol-6-yl sulfonamide derivatives, their preparation and their use in medicaments | |
| MA26906A1 (fr) | Aminoalkyl 1-lactames substituees et leur utilisation en tant qu'antagonistes du recepteur muscarinique | |
| EA200801909A1 (ru) | Соединения пиридина для лечения заболеваний, опосредованных действием простагландина | |
| NO20060342L (no) | 1-sulfonylindol derivater, deres fremstilling og deres andvendelse som 5-HT6 ligander | |
| TW200504014A (en) | Indol-5-yl sulfonamide derivatives, their preparation and their use in medicaments | |
| UY27685A1 (es) | Indolil-urea derivados de tienopiridinas útiles como agentes antiangiogénicos, y procedimientos para su uso | |
| NO20040589L (no) | Arylsulfonylderivater med 5-HT6 reseptor affinitet. | |
| NO20055492L (no) | Anvendelse av sulfonamidderivater for fremstilling av et medikament for profylakse og/eller behandling av lidelser ved matinntak | |
| CY1111836T1 (el) | Ενωσεις aminoalkoxy aryl sulfonamide και η χρηση τους σαν συνδετων (ligands) 5-ητ6 | |
| NO20080671L (no) | Bisykliske piperaziner som metabotrofiske glutamatreseptorantagonister | |
| NO20080669L (no) | Acetylenpiperaziner som metabotrofiske glutamatreseptorantagonister | |
| DE602004021385D1 (de) | Indol-4 -sulfonamid-derivate, ihre herstellung und verwendung als 5-ht-6 modulatoren | |
| DE602004016177D1 (de) | Methylindole und methylpyrrolopyridine als alpha-1-adrenerge agonisten | |
| NO20050903L (no) | Nye piperazinyl-pyrazinonderivater for behandling av 5HT-2A reseptorrelaterte forstyrrelser | |
| DK1517909T3 (da) | Tetracykliske arylcarbonylindoler med serotoninreceptor-affinitet til anvendelse som terpaeutiske midler, fremgangsmåde til fremstilling deraf og farmaceutiske sammensætninger indeholdende dem | |
| EA200702199A1 (ru) | Новые соединения для лечения воспалительных заболеваний |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1919475 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |